Anson Funds Management LP - RXI PHARMACEUTICALS CORP NEW ownership

RXI PHARMACEUTICALS CORP NEW's ticker is RXII and the CUSIP is 74979C303. A total of 25 filers reported holding RXI PHARMACEUTICALS CORP NEW in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Anson Funds Management LP ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q4 2015$328,000858,0680.11%
Other shareholders

There were no reported owners of RXI PHARMACEUTICALS CORP NEW in Q1 2016.

NameSharesValueWeighting ↓
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders